Fabio
102 lines
4.5 KiB
Markdown
102 lines
4.5 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)"
|
||
description: "Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)"
|
||
jurisdiction: "us/states/md"
|
||
legislature: "Maryland General Assembly"
|
||
session: "2022"
|
||
identifier: "HB 1397"
|
||
citation: "Maryland HB 1397 (2022)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["B. Barnes", "Bagnall", "Bhandari", "Carey", "Carr", "Charles", "Chisholm", "Cullison", "Henson", "Hill", "Howell", "Johnson", "K. Young", "Kaiser", "Kelly", "Kerr", "Kipke", "Landis", "Lehman", "Morgan", "Pena-Melnyk", "Pendergrass", "R. Lewis", "Reilly", "Reznik", "Rosenberg", "Saab", "Sample-Hughes", "Szeliga", "Valderrama", "Valentino-Smith"]
|
||
version_count: 3
|
||
action_count: 14
|
||
vote_count: 2
|
||
first_action: "2022-02-17"
|
||
last_action: "2022-05-16"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/51ee8ac3-c05f-4647-bff5-425b339347a8"
|
||
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1397?ys=2022RS&search=True"
|
||
source_hash: "5aff2044a224fb8c761518816584dd75c42d73d430ee53cff94b2e2081afb82f"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-md"]
|
||
---
|
||
|
||
# Maryland HB 1397 (2022) — Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Chapter - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)** (committee substitute) — [source](http://mgaleg.maryland.gov/2022RS/Chapters_noln/CH_405_hb1397t.pdf)
|
||
2. **First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)** (committee substitute) — [source](http://mgaleg.maryland.gov/2022RS/bills/hb/hb1397f.pdf)
|
||
3. **Third - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)** (committee substitute) — [source](http://mgaleg.maryland.gov/2022RS/bills/hb/hb1397t.pdf)
|
||
|
||
## Votes
|
||
|
||
- On Third Reading — **130–0** (pass) · lower
|
||
- On Third Reading — **45–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- B. Barnes — primary (person)
|
||
- Bagnall — primary (person)
|
||
- Bhandari — primary (person)
|
||
- Carey — primary (person)
|
||
- Carr — primary (person)
|
||
- Charles — primary (person)
|
||
- Chisholm — primary (person)
|
||
- Cullison — primary (person)
|
||
- Henson — primary (person)
|
||
- Hill — primary (person)
|
||
- Howell — primary (person)
|
||
- Johnson — primary (person)
|
||
- K. Young — primary (person)
|
||
- Kaiser — primary (person)
|
||
- Kelly — primary (person)
|
||
- Kerr — primary (person)
|
||
- Kipke — primary (person)
|
||
- Landis — primary (person)
|
||
- Lehman — primary (person)
|
||
- Morgan — primary (person)
|
||
- Pena-Melnyk — primary (person)
|
||
- Pendergrass — primary (person)
|
||
- R. Lewis — primary (person)
|
||
- Reilly — primary (person)
|
||
- Reznik — primary (person)
|
||
- Rosenberg — primary (person)
|
||
- Saab — primary (person)
|
||
- Sample-Hughes — primary (person)
|
||
- Szeliga — primary (person)
|
||
- Valderrama — primary (person)
|
||
- Valentino-Smith — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2022-02-17** First Reading House Rules and Executive Nominations `referral-committee`
|
||
- **2022-03-03** Rereferred to Health and Government Operations
|
||
- **2022-03-03** Hearing 3/15 at 1:30 p.m.
|
||
- **2022-03-18** Favorable with Amendments Report by Health and Government Operations `committee-passage-favorable`
|
||
- **2022-03-18** Favorable with Amendments { `committee-passage-favorable`
|
||
- **2022-03-18** Second Reading Passed with Amendments
|
||
- **2022-03-21** Third Reading Passed `passage`
|
||
- **2022-03-21** Referred Finance `referral-committee`
|
||
- **2022-04-04** Favorable Report by Finance `committee-passage-favorable`
|
||
- **2022-04-05** Favorable Adopted `committee-passage-favorable`
|
||
- **2022-04-05** Second Reading Passed
|
||
- **2022-04-06** Third Reading Passed `passage`
|
||
- **2022-04-07** Returned Passed
|
||
- **2022-05-16** Approved by the Governor - Chapter 405 `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/51ee8ac3-c05f-4647-bff5-425b339347a8`. Confidence: reported (aggregated from official Maryland legislature records).
|
||
|